TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL SPINE BIOLOGICS MARKET, BY PRODUCT
6.1. Overview
6.2. Bone Allografts
6.3. Bone Graft Substitute
6.4. Platelet Rich Plasma
6.5. Bone Marrow Aspirate Therapy
7. GLOBAL SPINE BIOLOGICS MARKET, BY SURGERY TYPE
7.1. Overview
7.2. Anterior Cervical Discectomy and Fusion (ACDF)
7.3. Transforamenal Lumbar Interbody Fusion (TLIF)
7.4. Anterior Lumbar Interbody Fusion (ALIF)
7.5. Lateral Lumbar Interbody Fusion (LLIF)
8. GLOBAL SPINE BIOLOGICS MARKET, BY END-USE
8.1. Overview
8.2. Hospitals
8.3. Spinal Surgery Centers
8.4. Others
9. GLOBAL SPINE BIOLOGICS MARKET, BY REGION
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. South Korea
9.4.5. Australia
9.4.6. Rest of Asia-Pacific
9.5. Rest of the World
9.5.1. Middle East
9.5.2. Africa
9.5.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Spine Biologics Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Spine Biologics Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Surgery Type Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022
11. COMPANY PROFILES
11.1. Arthrex, Inc.
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Cesca Therapeutics Inc.
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. DePuy Synthes
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Orthopaedic Seminar
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Exactech, Inc.
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. K2M, INC.
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Lattice Biologics Ltd
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Medtronic
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. NuTech Spine, Inc.
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. NuVasive Inc.
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Orthofix Holdings, Inc.
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Products Offered
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. Regen Lab USA LLC
11.12.1. Company Overview
11.12.2. Financial Overview
11.12.3. Products Offered
11.12.4. Key Developments
11.12.5. SWOT Analysis
11.12.6. Key Strategies
11.13. RTI Surgical Holdings, Inc.
11.13.1. Company Overview
11.13.2. Financial Overview
11.13.3. Products Offered
11.13.4. Key Developments
11.13.5. SWOT Analysis
11.13.6. Key Strategies
11.14. Stryker
11.14.1. Company Overview
11.14.2. Financial Overview
11.14.3. Products Offered
11.14.4. Key Developments
11.14.5. SWOT Analysis
11.14.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL SPINE BIOLOGICS MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL SPINE BIOLOGICS MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA SPINE BIOLOGICS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 10 U.S. SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 11 U.S. SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 12 U.S. SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 13 CANADA SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 14 CANADA SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 15 CANADA SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 16 EUROPE SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 17 EUROPE SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 18 EUROPE SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 19 EUROPE SPINE BIOLOGICS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 20 GERMANY SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 21 GERMANY SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 22 GERMANY SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 23 FRANCE SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 24 FRANCE SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 25 FRANCE SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 26 ITALY SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 27 ITALY SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 28 ITALY SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 29 SPAIN SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 30 SPAIN SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 31 SPAIN SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 32 U.K SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 33 U.K SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 34 U.K SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 35 REST OF EUROPE SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 36 REST OF EUROPE SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 37 REST OF EUROPE SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 38 ASIA PACIFIC SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 39 ASIA PACIFIC SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 40 ASIA PACIFIC SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 41 ASIA PACIFIC SPINE BIOLOGICS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 42 JAPAN SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 43 JAPAN SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 44 JAPAN SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 45 CHINA SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 46 CHINA SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 47 CHINA SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 48 INDIA SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 49 INDIA SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 50 INDIA SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 51 AUSTRALIA SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 52 AUSTRALIA SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 53 AUSTRALIA SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 54 SOUTH KOREA SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 55 SOUTH KOREA SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 56 SOUTH KOREA SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 57 REST OF ASIA-PACIFIC SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 58 REST OF ASIA-PACIFIC SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 59 REST OF ASIA-PACIFIC SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 60 REST OF WORLD SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 61 REST OF WORLD SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 62 REST OF WORLD SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 63 REST OF WORLD SPINE BIOLOGICS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 64 MIDDLE EAST SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 65 MIDDLE EAST SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 66 MIDDLE EAST SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 67 AFRICA SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 68 AFRICA SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 69 AFRICA SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 70 LATIN AMERICA SPINE BIOLOGICS MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 71 LATIN AMERICA SPINE BIOLOGICS MARKET, BY SURGERY TYPE, 2018-2032 (USD BILLION)
TABLE 72 LATIN AMERICA SPINE BIOLOGICS MARKET, BY END-USE, 2018-2032 (USD BILLION) 
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL SPINE BIOLOGICS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL SPINE BIOLOGICS MARKET
FIGURE 4 GLOBAL SPINE BIOLOGICS MARKET, SHARE (%), BY PRODUCT, 2022
FIGURE 5 GLOBAL SPINE BIOLOGICS MARKET, SHARE (%), BY SURGERY TYPE, 2022
FIGURE 6 GLOBAL SPINE BIOLOGICS MARKET, SHARE (%), BY END-USE, 2022
FIGURE 7 GLOBAL SPINE BIOLOGICS MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 NORTH AMERICA: SPINE BIOLOGICS MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 EUROPE: SPINE BIOLOGICS MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 ASIA-PACIFIC: SPINE BIOLOGICS MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 REST OF THE WORLD: SPINE BIOLOGICS MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 GLOBAL SPINE BIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 13 ARTHREX, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 ARTHREX, INC.: SWOT ANALYSIS
FIGURE 15 CESCA THERAPEUTICS INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 CESCA THERAPEUTICS INC.: SWOT ANALYSIS
FIGURE 17 DEPUY SYNTHES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 DEPUY SYNTHES: SWOT ANALYSIS
FIGURE 19 ORTHOPAEDIC SEMINAR: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 ORTHOPAEDIC SEMINAR: SWOT ANALYSIS
FIGURE 21 EXACTECH, INC..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 EXACTECH, INC..: SWOT ANALYSIS
FIGURE 23 K2M, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 K2M, INC.: SWOT ANALYSIS
FIGURE 25 LATTICE BIOLOGICS LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 LATTICE BIOLOGICS LTD: SWOT ANALYSIS
FIGURE 27 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 MEDTRONIC: SWOT ANALYSIS
FIGURE 29 NUTECH SPINE, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 NUTECH SPINE, INC.: SWOT ANALYSIS
FIGURE 31 NUVASIVE INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 NUVASIVE INC.: SWOT ANALYSIS
FIGURE 33 ORTHOFIX HOLDINGS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 ORTHOFIX HOLDINGS, INC.: SWOT ANALYSIS
FIGURE 35 REGEN LAB USA LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 REGEN LAB USA LLC: SWOT ANALYSIS
FIGURE 37 RTI SURGICAL HOLDINGS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 RTI SURGICAL HOLDINGS, INC.: SWOT ANALYSIS
FIGURE 39 STRYKER: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 40 STRYKER: SWOT ANALYSIS
